Literature DB >> 26586013

A new contemporary prostate cancer grading system.

Jonathan I Epstein1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26586013     DOI： 10.1016/j.annpat.2015.09.002

Source DB:  PubMed          Journal:  Ann Pathol        ISSN： 0242-6498            Impact factor:   0.407


× No keyword cloud information.
  5 in total

1.  Prostate Cancer Risk Stratification via Nondestructive 3D Pathology with Deep Learning-Assisted Gland Analysis.

Authors:  Weisi Xie; Nicholas P Reder; Can Koyuncu; Patrick Leo; Sarah Hawley; Hongyi Huang; Chenyi Mao; Nadia Postupna; Soyoung Kang; Robert Serafin; Gan Gao; Qinghua Han; Kevin W Bishop; Lindsey A Barner; Pingfu Fu; Jonathan L Wright; C Dirk Keene; Joshua C Vaughan; Andrew Janowczyk; Adam K Glaser; Anant Madabhushi; Lawrence D True; Jonathan T C Liu
Journal:  Cancer Res       Date:  2021-12-01       Impact factor: 13.312

Review 2.  The Role of Proteomics in Biomarker Development for Improved Patient Diagnosis and Clinical Decision Making in Prostate Cancer.

Authors:  Claire L Tonry; Emma Leacy; Cinzia Raso; Stephen P Finn; John Armstrong; Stephen R Pennington
Journal:  Diagnostics (Basel)       Date:  2016-07-18

3.  Cognitive function, depression, and anxiety in patients undergoing radical prostatectomy with and without adjuvant treatment.

Authors:  Piotr Jarzemski; Bartosz Brzoszczyk; Alicja Popiołek; Agnieszka Stachowicz-Karpińska; Szymon Gołota; Maciej Bieliński; Alina Borkowska
Journal:  Neuropsychiatr Dis Treat       Date:  2019-04-05       Impact factor: 2.570

4.  The Efficacy of Proclarix to Select Appropriate Candidates for Magnetic Resonance Imaging and Derived Prostate Biopsies in Men with Suspected Prostate Cancer.

Authors:  Juan Morote; Miriam Campistol; Anna Celma; Lucas Regis; Inés de Torres; María E Semidey; Sarai Roche; Richard Mast; Anna Santamaría; Jacques Planas; Enrique Trilla
Journal:  World J Mens Health       Date:  2021-12-27       Impact factor: 5.400

5.  A prognostic hypoxia gene signature with low heterogeneity within the dominant tumour lesion in prostate cancer patients.

Authors:  Unn Beate Salberg; Vilde Eide Skingen; Christina Sæten Fjeldbo; Tord Hompland; Harald Bull Ragnum; Ljiljana Vlatkovic; Knut Håkon Hole; Therese Seierstad; Heidi Lyng
Journal:  Br J Cancer       Date:  2022-03-24       Impact factor: 9.075
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.